Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank reduced its position in Addus HomeCare Co. (NASDAQ:ADUS) by 55.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,112 shares of the company’s stock after selling 5,166 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Addus HomeCare were worth $382,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. TimesSquare Capital Management LLC grew its stake in Addus HomeCare by 55.0% during the 3rd quarter. TimesSquare Capital Management LLC now owns 233,758 shares of the company’s stock valued at $19,914,000 after purchasing an additional 82,920 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Addus HomeCare by 4.9% during the third quarter. Vanguard Group Inc. now owns 1,218,564 shares of the company’s stock worth $103,809,000 after buying an additional 57,040 shares in the last quarter. Jacobs Levy Equity Management Inc. increased its stake in shares of Addus HomeCare by 127.7% in the third quarter. Jacobs Levy Equity Management Inc. now owns 100,158 shares of the company’s stock worth $8,532,000 after buying an additional 56,171 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in Addus HomeCare by 221.0% in the third quarter. Assenagon Asset Management S.A. now owns 71,321 shares of the company’s stock valued at $6,076,000 after acquiring an additional 49,101 shares in the last quarter. Finally, Summit Creek Advisors LLC boosted its stake in Addus HomeCare by 14.5% during the 3rd quarter. Summit Creek Advisors LLC now owns 288,158 shares of the company’s stock valued at $24,548,000 after acquiring an additional 36,578 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ADUS. William Blair restated an “outperform” rating on shares of Addus HomeCare in a research note on Monday, February 5th. Oppenheimer reaffirmed an “outperform” rating and set a $118.00 target price on shares of Addus HomeCare in a report on Tuesday, March 26th. Royal Bank of Canada reiterated an “outperform” rating and issued a $102.00 price target on shares of Addus HomeCare in a report on Thursday, February 29th. Finally, Barclays cut Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective on the stock. in a research note on Tuesday, April 23rd. One equities research analyst has rated the stock with a sell rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $103.00.

Addus HomeCare Price Performance

Shares of ADUS opened at $98.20 on Friday. Addus HomeCare Co. has a 12 month low of $77.30 and a 12 month high of $104.61. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. The stock has a fifty day moving average price of $98.27 and a 200 day moving average price of $92.19. The company has a market cap of $1.61 billion, a P/E ratio of 25.57, a PEG ratio of 1.94 and a beta of 0.96.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, February 26th. The company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.04 by $0.17. The business had revenue of $276.35 million during the quarter, compared to analyst estimates of $274.02 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. On average, research analysts forecast that Addus HomeCare Co. will post 4.38 earnings per share for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.